Rates of multiple angiomyolipomas, bilateral angiomyolipoma, renal angiomyolipoma lesions of >3 cm were significantly higher in those with TSC2 mutations than those with TSC1 mutations. This evidence concerns the gene TSC1 and angiomyolipoma.